Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1985 3
1986 2
1988 1
1989 1
1990 2
1992 2
1993 1
1998 1
1999 1
2000 2
2001 1
2002 1
2004 3
2005 1
2006 2
2007 2
2008 5
2009 3
2010 2
2011 1
2012 1
2013 3
2014 3
2016 2
2017 2
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

42 results
Results by year
Filters applied: . Clear all
Page 1
Cyclosporin A. Mode of action and effects on bone and joint tissues.
Russell RG, Graveley R, Coxon F, Skjodt H, Del Pozo E, Elford P, Mackenzie A. Russell RG, et al. Among authors: skjodt h. Scand J Rheumatol Suppl. 1992;95:9-18. doi: 10.3109/03009749209101478. Scand J Rheumatol Suppl. 1992. PMID: 1475634 Review.
Immune cells and bone resorption.
Gowen M, MacDonald BR, Hughes DE, Skjodt H, Russell RG. Gowen M, et al. Among authors: skjodt h. Adv Exp Med Biol. 1986;208:261-73. doi: 10.1007/978-1-4684-5206-8_33. Adv Exp Med Biol. 1986. PMID: 3105268 Review. No abstract available.
Glycemic control in diabetes in three Danish counties.
Jørgensen LG, Petersen PH, Heickendorff L, Møller HJ, Hendel J, Christensen C, Schmitz A, Reinholdt B, Lund ED, Christensen NJ, Hansen EK, Hastrup J, Skjødt H, Eriksen EW, Brandslund I. Jørgensen LG, et al. Among authors: skjodt h. Clin Chem Lab Med. 2005;43(12):1366-72. doi: 10.1515/CCLM.2005.233. Clin Chem Lab Med. 2005. PMID: 16309374
Differentiation between early rheumatoid arthritis patients and healthy persons by conventional and dynamic contrast-enhanced magnetic resonance imaging.
Axelsen MB, Ejbjerg BJ, Hetland ML, Skjødt H, Majgaard O, Lauridsen UB, Hørslev-Petersen K, Boesen M, Kubassova O, Bliddal H, Østergaard M. Axelsen MB, et al. Among authors: skjodt h. Scand J Rheumatol. 2014;43(2):109-18. doi: 10.3109/03009742.2013.824022. Epub 2013 Nov 6. Scand J Rheumatol. 2014. PMID: 24191910
Circulating surfactant protein -D is low and correlates negatively with systemic inflammation in early, untreated rheumatoid arthritis.
Christensen AF, Sørensen GL, Hørslev-Petersen K, Holmskov U, Lindegaard HM, Junker K, Hetland ML, Stengaard-Pedersen K, Jacobsen S, Lottenburger T, Ellingsen T, Andersen LS, Hansen I, Skjødt H, Pedersen JK, Lauridsen UB, Svendsen A, Tarp U, Pødenphant J, Vestergaard A, Jurik AG, Østergaard M, Junker P. Christensen AF, et al. Among authors: skjodt h. Arthritis Res Ther. 2010;12(2):R39. doi: 10.1186/ar2948. Epub 2010 Mar 8. Arthritis Res Ther. 2010. PMID: 20211020 Free PMC article. Clinical Trial.
Hand bone loss in early rheumatoid arthritis during a methotrexate-based treat-to-target strategy with or without adalimumab-a substudy of the optimized treatment algorithm in early RA (OPERA) trial.
Ørnbjerg LM, Østergaard M, Jensen T, Hørslev-Petersen K, Stengaard-Pedersen K, Junker P, Ellingsen T, Ahlquist P, Lindegaard H, Linauskas A, Schlemmer A, Dam MY, Hansen I, Lottenburger T, Ammitzbøll CG, Jørgensen A, Krintel SB, Raun J, Hetland ML; OPERA Study Group, Slot O, Nielsen LK, Skjødt H, Majgaard O, Lorenzen T, Horn HC, Kowalski M, Johansen IL, Pedersen PM, Manilo N, Bliddal H. Ørnbjerg LM, et al. Among authors: skjodt h. Clin Rheumatol. 2017 Apr;36(4):781-789. doi: 10.1007/s10067-016-3489-1. Epub 2016 Dec 5. Clin Rheumatol. 2017. PMID: 27921185 Clinical Trial.
42 results